RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.88
Price · May 20, 2026
Fundamentals as of May 6, 2026

RXRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.88
Market Cap
$2.16B
P/E (TTM)
-2.8
EPS (TTM)
$-1.44
Revenue (TTM)
$75M
Div Yield
ROE
-62.9%
Debt/Equity
52W Range
$3 – $7

RXRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $75M
7-point trend, +3120.4%
2019-12-31 2025-12-31
EPS $-1.44
7-point trend, +49.8%
2019-12-31 2025-12-31
Free Cash Flow $-378M
5-point trend, -90.7%
2021-12-31 2025-12-31
Margins -863.4%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
RXRX
Peer Median
P/E (TTM)
5-point trend, +75.3%
-2.8
P/S (TTM)
5-point trend, -89.9%
28.9
45.5
P/B
5-point trend, -64.4%
1.9
4.8
Price / FCF
5-point trend, +61.2%
-5.7

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
RXRX
Peer Median
Operating Margin
5-point trend, +51.7%
-867.9%
Net Profit Margin
5-point trend, +52.9%
-863.4%
-237.1%
ROA
5-point trend, -7.5%
-44.1%
-41.6%
ROE
5-point trend, -92.6%
-62.9%
-55.3%
ROIC
3-point trend, +23.2%
-57.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
RXRX
Peer Median
Current Ratio
5-point trend, -52.0%
5.5
5.7
Quick Ratio
5-point trend, -54.6%
5.0

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
RXRX
Peer Median
Revenue YoY
5-point trend, +633.7%
26.9%
Revenue CAGR 3Y
5-point trend, +633.7%
23.3%
Revenue CAGR 5Y
5-point trend, +633.7%
79.9%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
RXRX
Peer Median
EPS (Diluted)
5-point trend, +3.4%
$-1.44

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
RXRX
Peer Median

RXRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 14 analysts
  • Strong Buy 2 14.3%
  • Buy 6 42.9%
  • Hold 6 42.9%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

7 analysts · 2026-05-16
Median target $6.00 +108.5%
Mean target $6.64 +130.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.03%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.22 $-0.28 0.06%
Dec. 31, 2025 $-0.21 $-0.32 0.11%
Sept. 30, 2025 $-0.36 $-0.38 0.02%
June 30, 2025 $-0.41 $-0.36 -0.05%
March 31, 2025 $-0.50 $-0.54 0.04%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
RXRX $2.16B -2.8 26.9% -863.4% -62.9%
IOVA $1.12B -2.5 60.6% -148.4% -56.0%
INBX $1.15B -8.7 550.0% -10773.5% -365.9%
GLUE $1.03B 63.5% -31.2% -15.4%
ARDX $1.42B -22.4 22.1% -15.1% -40.2%
TSHA $1.57B -16.2 17.3% -1115.3% -44.0%
PGEN $1.48B -3.1 146.7% -2588.2% 3159.1%
NVAX $1.09B 2.6 64.7% 39.2% -977.1%
DMRA 38.3% -17981.1% -167.0%
VIR $841M -1.9 -7.6% -638.9% -51.1%
KALV $685M -3.7 -172.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 16
Annual Income Statement data for RXRX
Metric Trend 2025202420232022202120202019
Revenue 7-point trend, +3120.4% $75M $59M $45M $40M $10M $4M $2M
Cost of Revenue 6-point trend, +70953000.00 $71M $45M $43M $48M $0 $0 ·
R&D Expense 7-point trend, +937.5% $475M $314M $241M $156M $135M $63M $46M
SG&A Expense 7-point trend, +831.8% $177M $178M $111M $82M $58M $25M $19M
Operating Expenses 7-point trend, +1016.1% $723M $538M $395M $286M $193M $89M $65M
Operating Income 7-point trend, -938.0% $-648M $-479M $-350M $-246M $-183M $-85M $-62M
Interest Expense 5-point trend, -84.7% · · $97.0K $55.0K $3M $1M $635.0K
Other Non-op 7-point trend, +476.0% $3M $14M $18M $6M $-4M $-2M $562.0K
Pretax Income 5-point trend, -245.8% $-645M $-465M $-332M $-239M $-186M · ·
Income Tax 7-point trend, -136000.00 $-136.0K $-1M $-4M $0 $0 $0 $0
Net Income 7-point trend, -942.0% $-645M $-464M $-328M $-239M $-186M $-87M $-62M
EPS (Basic) 7-point trend, +49.8% $-1.44 $-1.69 $-1.58 $-1.36 $-1.49 $-3.99 $-2.87
EPS (Diluted) 7-point trend, +49.8% $-1.44 $-1.69 $-1.58 $-1.36 $-1.49 $-3.99 $-2.87
Shares (Basic) 7-point trend, +1974.4% 447,446,109 274,207,146 207,853,702 175,537,487 125,348,110 21,781,386 21,570,265
Shares (Diluted) 7-point trend, +1974.4% 447,446,109 274,207,146 207,853,702 175,537,487 125,348,110 21,781,386 21,570,265
EBITDA 5-point trend, -223.7% $-564M $-443M $-326M $-234M $-174M · ·
Balance Sheet 30
Annual Balance Sheet data for RXRX
Metric Trend 2025202420232022202120202019
Cash & Equivalents 6-point trend, +183.6% $743M $594M $392M $550M $285M $262M ·
Short-term Investments 3-point trend, +0.00 · · · $0 $231M $0 ·
Receivables 3-point trend, -100.0% · · · $0 $34.0K $156.0K ·
Prepaid Expense 2-point trend, -60.3% $12M $30M · · · · ·
Other Current Assets 6-point trend, +1225.6% $29M $38M $40M $16M $8M $2M ·
Current Assets 6-point trend, +205.1% $813M $714M $438M $570M $535M $266M ·
PP&E (Net) 6-point trend, +300.2% $104M $141M $87M $88M $65M $26M ·
PP&E (Gross) 6-point trend, +437.6% $193M $204M $131M $118M $83M $36M ·
Accum. Depreciation 6-point trend, +795.5% $89M $63M $45M $30M $19M $10M ·
Goodwill 6-point trend, +20144.4% $162M $149M $52M $801.0K $801.0K $801.0K ·
Intangibles 6-point trend, +18248.3% $310M $336M $36M $1M $1M $2M ·
Other Non-current Assets 6-point trend, +1862.2% $13M $9M $261.0K $0 $35.0K $650.0K ·
Total Assets 6-point trend, +393.7% $1.47B $1.45B $654M $701M $610M $299M ·
Accounts Payable 6-point trend, +1587.0% $18M $22M $4M $5M $3M $1M ·
Accrued Liabilities 6-point trend, +569.8% $70M $82M $47M $33M $32M $10M ·
Short-term Debt 4-point trend, -96.2% · · $41.0K $97.0K $90.0K $1M ·
Current Liabilities 6-point trend, +539.5% $148M $187M $93M $100M $47M $23M ·
Capital Leases 5-point trend, +46647000.00 $47M $67M $43M $44M $0 · ·
Deferred Tax 4-point trend, +23255000.00 $23M $17M $1M $0 · · ·
Other Non-current Liabilities 3-point trend, +2080000.00 $2M $5M $0 · · · ·
Total Liabilities 6-point trend, +506.9% $343M $414M $190M $215M $67M $57M ·
Long-term Debt · · · · $723.0K · ·
Total Debt 3-point trend, -54.4% · · $41.0K $97.0K $90.0K · ·
Common Stock 6-point trend, +5000.00 $5.0K $4.0K $2.0K $2.0K $2.0K $0 ·
Paid-in Capital 6-point trend, +43255.4% $3.17B $2.47B $1.43B $1.13B $943M $7M ·
Retained Earnings 6-point trend, -871.9% $-2.08B $-1.43B $-968M $-640M $-400M $-214M ·
AOCI 6-point trend, +36717000.00 $37M $-8M $0 $0 $-126.0K $0 ·
Stockholders' Equity 7-point trend, +1010.0% $1.13B $1.03B $463M $486M $543M $-206M $-124M
Liabilities + Equity 6-point trend, +393.7% $1.47B $1.45B $654M $701M $610M $299M ·
Shares Outstanding 7-point trend, +2341.0% 528,182,693 396,802,394 234,270,384 191,022,864 170,272,462 22,314,685 21,637,609
Cash Flow 17
Annual Cash Flow data for RXRX
Metric Trend 2025202420232022202120202019
D&A 7-point trend, +3262.8% $84M $36M $24M $12M $8M $4M $2M
Stock-based Comp 7-point trend, +7930.5% $111M $82M $54M $28M $15M $4M $1M
Deferred Tax 4-point trend, -368000.00 $-368.0K $-2M $-4M $0 · · ·
Amort. of Intangibles 7-point trend, +50300000.00 $50M $19M $8M $379.0K $304.0K $126.0K $0
Restructuring $10M · · · · · ·
Other Non-cash 5-point trend, +1597.6% $78M $-12M $-38M $116M $5M · ·
Operating Cash Flow 7-point trend, -551.8% $-372M $-359M $-288M $-84M $-159M $-45M $-57M
CapEx 7-point trend, +65.4% $6M $14M $12M $37M $40M $6M $4M
Investing Cash Flow 7-point trend, -331.5% $-17M $260M $-10M $193M $-272M $-9M $-4M
Net Debt Issued 3-point trend, +94.0% · · $-766.0K $-90.0K $-13M · ·
Stock Issued 6-point trend, +528864000.00 $529M $300M $128M $144M $463M $0 ·
Net Stock Activity 4-point trend, +268.0% $529M $300M $128M $144M · · ·
Financing Cash Flow 7-point trend, +333.1% $522M $304M $140M $154M $459M $246M $120M
Net Change in Cash 7-point trend, +153.8% $151M $202M $-158M $264M $28M $192M $59M
Taxes Paid 2-point trend, +237000.00 $237.0K $0 · · · · ·
Free Cash Flow 5-point trend, -90.7% $-378M $-373M $-300M $-121M $-198M · ·
Levered FCF · · $-300M · · · ·
Profitability 7
Annual Profitability data for RXRX
Metric Trend 2025202420232022202120202019
Operating Margin 5-point trend, +51.7% -867.9% -814.1% -785.3% -616.7% -1795.8% · ·
Net Margin 5-point trend, +52.9% -863.4% -788.0% -736.0% -601.1% -1832.2% · ·
Pretax Margin 3-point trend, -15.9% -863.5% -789.9% -745.1% · · · ·
EBITDA Margin 5-point trend, +55.9% -755.8% -752.1% -730.6% -587.2% -1713.2% · ·
ROA 5-point trend, -7.5% -44.1% -44.1% -48.4% -36.5% -41.0% · ·
ROE 5-point trend, -92.6% -62.9% -59.5% -72.8% -54.8% -32.7% · ·
ROIC 3-point trend, +23.2% -57.3% -46.2% -74.6% · · · ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for RXRX
Metric Trend 2025202420232022202120202019
Current Ratio 5-point trend, -52.0% 5.5 3.8 4.7 5.7 11.5 · ·
Quick Ratio 5-point trend, -54.6% 5.0 3.2 4.2 5.5 11.1 · ·
Debt / Equity 3-point trend, -50.0% · · 0.0 0.0 0.0 · ·
Interest Coverage 3-point trend, -5728.7% · · -3608.9 -4467.8 -61.9 · ·
Efficiency 2
Annual Efficiency data for RXRX
Metric Trend 2025202420232022202120202019
Asset Turnover 5-point trend, +128.1% 0.1 0.1 0.1 0.1 0.0 · ·
Receivables Turnover 2-point trend, +2087.6% · · · 2343.7 107.1 · ·
Per Share 5
Annual Per Share data for RXRX
Metric Trend 2025202420232022202120202019
Book Value / Share 5-point trend, -32.9% $2.14 $2.61 $1.98 $2.54 $3.19 · ·
Revenue / Share 5-point trend, +105.5% $0.17 $0.21 $0.21 $0.23 $0.08 · ·
Cash Flow / Share 5-point trend, +34.3% $-0.83 $-1.31 $-1.38 $-0.48 $-1.27 · ·
Cash / Share 5-point trend, -16.0% $1.41 $1.50 $1.67 $2.88 $1.67 · ·
EPS (TTM) 5-point trend, +3.4% $-1.44 $-1.69 $-1.58 $-1.36 $-1.49 · ·
Growth Rates 3
Annual Growth Rates data for RXRX
Metric Trend 2025202420232022202120202019
Revenue YoY 5-point trend, -82.8% 26.9% 32.0% 11.9% 291.5% 156.9% · ·
Revenue CAGR 3Y 3-point trend, -81.2% 23.3% 79.5% 124.1% · · · ·
Revenue CAGR 5Y 79.9% · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for RXRX
Metric Trend 2025202420232022202120202019
Revenue TTM 5-point trend, +633.7% $75M $59M $45M $40M $10M · ·
Net Income TTM 5-point trend, -245.8% $-645M $-464M $-328M $-239M $-186M · ·
Market Cap 5-point trend, -25.9% $2.16B $2.68B $2.31B $1.47B $2.92B · ·
Enterprise Value 3-point trend, -20.1% · · $1.92B $923M $2.40B · ·
P/E 5-point trend, +75.3% -2.8 -4.0 -6.2 -5.7 -11.5 · ·
P/S 5-point trend, -89.9% 28.9 45.6 51.8 37.0 286.6 · ·
P/B 5-point trend, -64.4% 1.9 2.6 5.0 3.0 5.4 · ·
P / Tangible Book 5-point trend, -39.2% 3.3 4.9 6.2 3.0 5.4 · ·
P / Cash Flow 5-point trend, +68.4% -5.8 -7.5 -8.0 -17.6 -18.4 · ·
P / FCF 5-point trend, +61.2% -5.7 -7.2 -7.7 -12.2 -14.7 · ·
EV / EBITDA 3-point trend, +57.2% · · -5.9 -3.9 -13.8 · ·
EV / FCF 3-point trend, +47.1% · · -6.4 -7.7 -12.1 · ·
EV / Revenue 3-point trend, -81.8% · · 43.0 23.2 235.8 · ·
Earnings Yield 5-point trend, -304.7% -35.2% -25.0% -16.0% -17.6% -8.7% · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $75M$59M$45M$40M$10M
Operating Margin % -867.9%-814.1%-785.3%-616.7%-1795.8%
Net Income $-645M$-464M$-328M$-239M$-186M
Diluted EPS $-1.44$-1.69$-1.58$-1.36$-1.49
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.00.00.0
Current Ratio 5.53.84.75.711.5
Quick Ratio 5.03.24.25.511.1
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-378M$-373M$-300M$-121M$-198M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.